Integra LifeSciences Holdings (IART) Gross Profit Margin: History & Chart

Integra LifeSciences Holdings Corporation(IART)

Medical - Devices · Princeton, NJ

$13.32+0.03 (+0.23%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Princeton, NJ

4,427 employees

www.integralife.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stuart Essig

View full financials

IART Gross Margin Metrics

GROSS MARGIN

53.74%

GROSS MARGIN AVG TTM

53.16%

GROSS MARGIN AVG 3Y

54.15%

GROSS MARGIN AVG 5Y

57.13%

GROSS MARGIN AVG 10Y

59.81%

GROSS MARGIN AVG 15Y

61.55%

GROSS MARGIN AVG 20Y

61.68%

CURRENT VS TTM AVG

+1.09%

CURRENT VS 3Y AVG

-0.77%

CURRENT VS 5Y AVG

-5.93%

CURRENT VS 10Y AVG

-10.14%

CURRENT VS 15Y AVG

-12.69%

CURRENT VS 20Y AVG

-12.87%

SECTOR MEDIAN · HEALTHCARE

41.20%

median of 862 covered companies

CURRENT VS SECTOR MEDIAN

+30.42%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
Integra LifeSciences Holdings Corporation (IART)	$1.04B	53.74%	53.16%	54.15%	57.13%
Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›	$1.03B	11.80%	10.80%	10.72%	10.72%
Janux Therapeutics, Inc. (JANX)vs ›	$1.02B	79.71%	80.13%	81.57%	-49.18%
Teladoc Health, Inc. (TDOC)vs ›	$1.05B	73.53%	70.13%	70.04%	68.74%
Castle Biosciences, Inc. (CSTL)vs ›	$1.02B	77.26%	80.62%	79.35%	80.86%
Immatics N.V. (IMTX)vs ›	$1.01B	100.00%	100.00%	100.00%	64.23%
Cullinan Therapeutics, Inc. (CGEM)vs ›	$998.69M	0.00%	0.00%	0.00%	16.67%
PROCEPT BioRobotics Corporation (PRCT)vs ›	$996.65M	63.74%	62.39%	56.59%	42.69%
Vor Biopharma Inc. (VOR)vs ›	$992.14M	0.00%	0.00%	0.00%	0.00%
IRadimed Corporation (IRMD)vs ›	$1.08B	75.86%	76.84%	76.91%	76.44%

NAME

MARKET CAP

GROSS MARGIN

TTM

Integra LifeSciences Holdings Corporation (IART)

$1.04B

53.74%

53.16%

54.15%

57.13%

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›

$1.03B

11.80%

10.80%

10.72%

Janux Therapeutics, Inc. (JANX)vs ›

$1.02B

79.71%

80.13%

81.57%

-49.18%

Teladoc Health, Inc. (TDOC)vs ›

$1.05B

73.53%

70.13%

70.04%

68.74%

Castle Biosciences, Inc. (CSTL)vs ›

$1.02B

77.26%

80.62%

79.35%

80.86%

Immatics N.V. (IMTX)vs ›

$1.01B

100.00%

64.23%

Cullinan Therapeutics, Inc. (CGEM)vs ›

$998.69M

0.00%

16.67%

PROCEPT BioRobotics Corporation (PRCT)vs ›

$996.65M

63.74%

62.39%

56.59%

42.69%

Vor Biopharma Inc. (VOR)vs ›

$992.14M

0.00%

IRadimed Corporation (IRMD)vs ›

$1.08B

75.86%

76.84%

76.91%

76.44%

Gross Margin FAQ

What is the gross margin for Integra LifeSciences Holdings Corporation (IART)?

The gross margin for IART stock is 53.74%.

Is Integra LifeSciences Holdings Corporation's gross margin high or low?

The gross margin of 53.74% is in line with its 5-year average of 57.13%, around the middle of its 5-year range (49.52%–62.83%).

What is the TTM average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The TTM average gross margin for IART stock is 53.16%.

What is the 3Y average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The 3Y average gross margin for IART stock is 54.15%.

What is the 5Y average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The 5Y average gross margin for IART stock is 57.13%.

What is the 10Y average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The 10Y average gross margin for IART stock is 59.81%.

What is the 15Y average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The 15Y average gross margin for IART stock is 61.55%.

What is the 20Y average gross margin for Integra LifeSciences Holdings Corporation (IART)?

The 20Y average gross margin for IART stock is 61.68%.

DATE	GROSS MARGIN
2026-06-30	52.47%
2026-03-31	57.22%
2025-12-31	49.52%
2025-09-30	56.24%
2025-06-30	50.37%
2025-03-31	50.81%
2024-12-31	56.27%
2024-09-30	52.58%
2024-06-30	54.02%
2024-03-31	56.07%
2023-12-31	57.05%
2023-09-30	57.10%
2023-06-30	54.30%
2023-03-31	61.15%
2022-12-31	62.83%
2022-09-30	61.46%
2022-06-30	62.70%
2022-03-31	62.15%
2021-12-31	61.47%
2021-09-30	62.66%
2021-06-30	61.21%
2021-03-31	59.50%
2020-12-31	62.16%
2020-09-30	63.59%
2020-06-30	59.22%
2020-03-31	62.33%
2019-12-31	62.17%
2019-09-30	62.37%
2019-06-30	62.55%
2019-03-31	64.16%
2018-12-31	61.79%
2018-09-30	60.85%
2018-06-30	62.43%
2018-03-31	59.61%
2017-12-31	59.80%
2017-09-30	63.51%
2017-06-30	64.91%
2017-03-31	66.52%
2016-12-31	66.59%
2016-09-30	64.32%
2016-06-30	64.07%
2016-03-31	64.20%
2015-12-31	62.68%
2015-09-30	61.98%
2015-06-30	64.54%
2015-03-31	62.89%
2014-12-31	61.35%
2014-09-30	62.57%
2014-06-30	62.41%
2014-03-31	61.69%
2013-12-31	60.75%
2013-09-30	60.56%
2013-06-30	59.59%
2013-03-31	59.18%
2012-12-31	61.79%
2012-09-30	62.14%
2012-06-30	62.76%
2012-03-31	61.94%
2011-12-31	59.35%
2011-09-30	61.10%
2011-06-30	62.32%
2011-03-31	64.14%
2010-12-31	63.27%
2010-09-30	62.93%
2010-06-30	63.90%
2010-03-31	63.39%
2009-12-31	65.16%
2009-09-30	63.42%
2009-06-30	63.91%
2009-03-31	63.87%
2008-12-31	60.92%
2008-09-30	61.49%
2008-06-30	63.00%
2008-03-31	60.12%
2007-12-31	60.40%
2007-09-30	62.33%
2007-06-30	60.82%
2007-03-31	60.52%
2006-12-31	58.97%
2006-09-30	59.23%
2006-06-30	58.68%
2006-03-31	63.78%
2005-12-31	61.29%
2005-09-30	62.48%
2005-06-30	61.11%
2005-03-31	63.35%
2004-12-31	62.43%
2004-09-30	62.10%
2004-06-30	61.61%
2004-03-31	61.86%
2003-12-31	64.53%
2003-09-30	59.90%
2003-06-30	60.01%
2003-03-31	62.74%
2002-12-31	52.87%
2002-09-30	58.25%

DATE

GROSS MARGIN

2026-06-30

52.47%

2026-03-31

57.22%

2025-12-31

49.52%

2025-09-30

56.24%

2025-06-30

50.37%

2025-03-31

50.81%

2024-12-31

56.27%

2024-09-30

52.58%

2024-06-30

54.02%

2024-03-31

56.07%

2023-12-31

57.05%

2023-09-30

57.10%

2023-06-30

54.30%

2023-03-31

61.15%

2022-12-31

62.83%

2022-09-30

61.46%

2022-06-30

62.70%

2022-03-31

62.15%

2021-12-31

61.47%

2021-09-30

62.66%

2021-06-30

61.21%

2021-03-31

59.50%

2020-12-31

62.16%

2020-09-30

63.59%

2020-06-30

59.22%

2020-03-31

62.33%

2019-12-31

62.17%

2019-09-30

62.37%

2019-06-30

62.55%

2019-03-31

64.16%

2018-12-31

61.79%

2018-09-30

60.85%

2018-06-30

62.43%

2018-03-31

59.61%

2017-12-31

59.80%

2017-09-30

63.51%

2017-06-30

64.91%

2017-03-31

66.52%

2016-12-31

66.59%

2016-09-30

64.32%

2016-06-30

64.07%

2016-03-31

64.20%

2015-12-31

62.68%

2015-09-30

61.98%

2015-06-30

64.54%

2015-03-31

62.89%

2014-12-31

61.35%

2014-09-30

62.57%

2014-06-30

62.41%

2014-03-31

61.69%

2013-12-31

60.75%

2013-09-30

60.56%

2013-06-30

59.59%

2013-03-31

59.18%

2012-12-31

61.79%

2012-09-30

62.14%

2012-06-30

62.76%

2012-03-31

61.94%

2011-12-31

59.35%

2011-09-30

61.10%

2011-06-30

62.32%

2011-03-31

64.14%

2010-12-31

63.27%

2010-09-30

62.93%

2010-06-30

63.90%

2010-03-31

63.39%

2009-12-31

65.16%

2009-09-30

63.42%

2009-06-30

63.91%

2009-03-31

63.87%

2008-12-31

60.92%

2008-09-30

61.49%

2008-06-30

63.00%

2008-03-31

60.12%

2007-12-31

60.40%

2007-09-30

62.33%

2007-06-30

60.82%

2007-03-31

60.52%

2006-12-31

58.97%

2006-09-30

59.23%

2006-06-30

58.68%

2006-03-31

63.78%

2005-12-31

61.29%

2005-09-30

62.48%

2005-06-30

61.11%

2005-03-31

63.35%

2004-12-31

62.43%

2004-09-30

62.10%

2004-06-30

61.61%

2004-03-31

61.86%

2003-12-31

64.53%

2003-09-30

59.90%

2003-06-30

60.01%

2003-03-31

62.74%

2002-12-31

52.87%

2002-09-30

58.25%

Gross Margin: 53.74%

IART Gross Margin

IART Average Gross Margin Chart

IART Current vs Average Gross Margin Chart

IART Gross Margin Metrics

IART Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

IART Gross Margin History

Related Metrics